DOI: 10.1055/s-00029029

Journal of Pediatric Intensive Care

Referenz

Mahat U, Matar RB, Rotz SJ.
Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.

Pediatr Blood Cancer 2019;
66 (11) e27913

Bibliographische Angaben herunterladen

Aufrufen in: